Black Diamond Therapeutics Inc

BDTXNASDAQ · USD
1.95USD+0.02 (+0.78%)
235

Black Diamond Therapeutics Inc (BDTX) Straddle

BDTX straddle scan found 17 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 59.1%.

Read more

Trading a BDTX straddle lets you take a pure volatility position on Black Diamond Therapeutics Inc without committing to a direction. Black Diamond Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate BDTX straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on BDTX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Black Diamond Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the BDTX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations.

It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the BDTX straddle is the cleanest expression of that view. Our scanner prices every BDTX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a BDTX straddle into a catalyst or short a BDTX straddle to harvest decay, the options straddle setups that matter are all in one place.

Dec 17, 20277.50$6.4045611%59.1%$13.90$1.100
Sep 17, 20277.50$6.3536511%55.6%$13.85$1.150
Dec 17, 20275.00$4.1545611%53.2%$9.15$0.851
Sep 17, 20275.00$4.0036511%52.7%$9.00$1.000
Jun 17, 20275.00$3.8527311%51.0%$8.85$1.150
Jun 17, 20272.50$1.9027311%34.8%$4.40$0.600
Dec 18, 20262.00$1.039211%33.7%$3.03$0.9832
Dec 17, 20272.50$2.2045611%30.8%$4.70$0.300
Jun 17, 20272.00$1.7027311%21.8%$3.70$0.300
Sep 17, 20272.50$2.2536511%21.0%$4.75$0.250

As of September 17, 2026

Find the right straddle before volatility moves

Track BDTX straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial